Israel’s BioProtect (see here previously) has received US FDA’s clearance for its biodegradable balloon spacer that protects healthy tissue against damage during prostate cancer radiation therapy. BioProtect already has approval for the European market.
US approval for biodegradable balloon
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.